Jeffrey Ubben
ValueAct Holdings
ValueAct Holdings Portfolio 13F
Jeffrey Ubben Holdings Activity
- Portfolio value:
- $9.98B≈ (-$1B≈)
- Previous value:
- $11.19B≈
- # of changes:
- 12
- New positions:
- 1
- Reported for:
- 30 Sep 2017 (Q3)
- Latest filing date:
- 14 Nov 2017
ValueAct Holdings has disclosed a total of 12 changes to the portfolio in the (2017 Q3) SEC report(s): increased the number of shares of 5, bought 1 totally new, decreased the number of shares of 4 and completely sold out 2 position(s).
What stocks did Jeffrey Ubben buy in 2017 Q3?
During 2017 Q3 Jeffrey Ubben has bought 6 securities out of which top 5 purchases (by % change to portfolio) were (BKR) Baker Hughes Co (new buy), (KKR) KKR & Co Inc (added shares +811.12%), (STX) SEAGATE TECHNOLOGY ULC (added shares +55.32%), (TRN) Trinity Industries Inc (added shares +10.73%) and (AWI) Armstrong World Industries Inc (added shares +0.03%).
12 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Baker Hughes Co
|
new
|
$36.62
|
+67.91%($61.49)
|
11.53%
|
2017 Q3
|
≈ 0.25 years
|
||||
|
|
KKR & Co Inc
|
+811.12%
|
$20.33
|
+429.37%($107.62)
|
9.28%
|
2017 Q2
|
≈ 0.50 years
|
||||
|
|
SEAGATE TECHNOLOGY ULC
|
+55.32%
|
$33.17
|
+2,526.76%($871.30)
|
7.13%
|
2016 Q2
|
≈ 1.50 years
|
||||
|
|
Trinity Industries Inc
|
+10.73%
|
$31.90
|
-0.13%($31.86)
|
5.52%
|
2016 Q2
|
≈ 1.50 years
|
||||
|
|
Valeant Pharmaceuticals International Inc
|
+0.07%
|
$14.33
|
|
2.59%
|
2013 Q2 or earlier
|
≈ 4.50+ years
|
||||
|
|
Armstrong World Industries Inc
|
+0.03%
|
$51.25
|
+255.50%($182.20)
|
4.73%
|
2014 Q2
|
≈ 3.50 years
|
||||
|
|
CBRE Group Inc, CL-A
|
-16.00%
|
$37.88
|
+294.80%($149.55)
|
10.96%
|
2013 Q2 or earlier
|
≈ 4.50+ years
|
||||
|
|
Microsoft Corp
|
-43.71%
|
$74.49
|
+565.85%($495.99)
|
6.73%
|
2013 Q2 or earlier
|
≈ 4.50+ years
|
||||
|
|
Willis Towers Watson PLC
|
-54.91%
|
$154.23
|
+118.66%($337.24)
|
4.61%
|
2016 Q1
|
≈ 1.75 years
|
||||
|
|
Bioverativ Inc
|
-82.26%
|
$57.07
|
|
0.73%
|
2017 Q1
|
≈ 0.75 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.